BlossomHill Therapeutics, Inc. (BLSM) SEC filings
BLSMNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026
$14.02−0.82 (-5.53%)
Close on Nov 13, 2026Market cap $35.73MP/E –Yield –
SEC filings
6 of BlossomHill Therapeutics's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Quarterly report | 10-Q | Sep 30, 2026 | Nov 12, 2026 | SEC EDGAR |
| Current report | 8-K | Nov 12, 2026 | Nov 12, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2026 | Sep 18, 2026 | SEC EDGAR |
| Current report | 8-K | Sep 18, 2026 | Sep 18, 2026 | SEC EDGAR |
| Current report | 8-K | Sep 15, 2026 | Sep 15, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 10, 2026 | Aug 10, 2026 | SEC EDGAR |
See a number that looks wrong?